Hooke Bio is excited to be attending Antibody Engineering & Therapeutics Europe 2025 in Basel, Switzerland, this June.
Representing Hooke Bio at the conference will be Dr. Finola Cliffe, Veasna Sum Coffey and Sandra Sunil. The team will be meeting with researchers, collaborators and industry partners to discuss how the Mera™ Microphysiological System is supporting the development of next-generation antibody therapeutics.
We’re also delighted that Dr. Finola Cliffe will be speaking at the conference, sharing insights into how human-relevant, flow-based microphysiological systems can provide more predictive preclinical data for antibody and immunotherapy development.
Mera combines human-relevant 3D tissue models with dynamic flow to provide more predictive preclinical data, enabling the assessment of therapeutic efficacy, immune cell interactions, cytokine responses and safety in physiologically relevant conditions.
If you’re developing monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs) or other innovative biologics, we’d love to discuss how Hooke Bio can help accelerate your preclinical research.
Attending the conference? Come and connect with Finola, Veasna and Sandra in Basel—we look forward to meeting you!
